Petersen, Peter C., Lone N. Petersen, Ivan Vogelius, Jon K. Bjerregaard, and Lene Baeksgaard. “A Randomized Phase 2 Trial of First-Line Docetaxel, Carboplatin, Capecitabine (CTX) and Epirubicin, Oxaliplatin, Capecitabine (EOX) in Advanced Esophagogastric Adenocarcinoma”. Acta Oncologica 60, no. 7 (July 3, 2021): 948–953. Accessed June 26, 2026. https://medicaljournalssweden.se/actaoncologica/article/view/24015.